These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22244256)

  • 41. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
    van Baarle D; Hovenkamp E; Callan MF; Wolthers KC; Kostense S; Tan LC; Niesters HG; Osterhaus AD; McMichael AJ; van Oers MH; Miedema F
    Blood; 2001 Jul; 98(1):146-55. PubMed ID: 11418474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
    Piriou E; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Blood; 2005 Nov; 106(9):3166-74. PubMed ID: 16014568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
    Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
    HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
    Achenbach CJ; Buchanan AL; Cole SR; Hou L; Mugavero MJ; Crane HM; Moore RD; Haubrich RH; Gopal S; Eron JJ; Hunt PW; Rodriguez B; Mayer K; Saag MS; Kitahata MM;
    Clin Infect Dis; 2014 Jun; 58(11):1599-606. PubMed ID: 24523217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of early HIV viremia with mortality after HIV-associated lymphoma.
    Gopal S; Patel MR; Yanik EL; Cole SR; Achenbach CJ; Napravnik S; Burkholder GA; Reid EG; Rodriguez B; Deeks SG; Mayer KH; Moore RD; Kitahata MM; Richards KL; Eron JJ
    AIDS; 2013 Sep; 27(15):2365-73. PubMed ID: 23736149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
    Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
    Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
    Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
    J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
    Barta SK; Samuel MS; Xue X; Wang D; Lee JY; Mounier N; Ribera JM; Spina M; Tirelli U; Weiss R; Galicier L; Boue F; Little RF; Dunleavy K; Wilson WH; Wyen C; Remick SC; Kaplan LD; Ratner L; Noy A; Sparano JA
    Ann Oncol; 2015 May; 26(5):958-966. PubMed ID: 25632071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
    Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
    AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy.
    Castillo JJ; Furman M; Beltrán BE; Bibas M; Bower M; Chen W; Díez-Martín JL; Liu JJ; Miranda RN; Montoto S; Nanaji NM; Navarro JT; Seegmiller AC; Vose JM
    Cancer; 2012 Nov; 118(21):5270-7. PubMed ID: 22510767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral T-cell lymphoma in HIV-infected patients: a study of 17 cases in the combination antiretroviral therapy era.
    Gilardin L; Copie-Bergman C; Galicier L; Meignin V; Brière J; Timsit JF; Bouchaud O; Gaulard P; Oksenhendler E; Gérard L
    Br J Haematol; 2013 Jun; 161(6):843-51. PubMed ID: 23593987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.
    Smith DM; Nakazawa M; Freeman ML; Anderson CM; Oliveira MF; Little SJ; Gianella S
    Clin Infect Dis; 2016 Dec; 63(11):1517-1524. PubMed ID: 27601222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for pediatric human immunodeficiency virus-related malignancy.
    Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
    JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma.
    Ul-Haq I; Dalla Pria A; Suardi E; Pinato DJ; Froeling F; Forni J; Randell P; Bower M
    Med Oncol; 2018 Mar; 35(4):53. PubMed ID: 29536181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.
    ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro Murillo AM; Mocroft A; Bonnet F; Clifford G; Touloumi G; Miro JM; Chene G; Lundgren J; Egger M
    AIDS; 2009 Sep; 23(15):2029-37. PubMed ID: 19531926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.